4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-107903
Chief Legal Officer sold 500 shares at $16.33 ($8,165)
- Chief Legal Officer acquired 500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bizily Scott Chief Legal Officer | 2024-09-16 | Option exercise 10b5-1 | +500 | $6.49 | $3,245 | 7,281 | D |
| Bizily Scott Chief Legal Officer | 2024-09-16 | Sale 10b5-1 | −500 | $16.33 | $8,165 | 6,781 | D |
| Derivatives | |||||||
| Bizily Scott Chief Legal Officer | 2024-09-16 | Option exercise · Stock Option (Right To Buy) 10b5-1 | −500 | 10,379 | D | ||
| Open-market sales · 500 sh · avg $16.33 · $8,165 | |||||||
Loading xslF345X05/ownership.xml…